Literature DB >> 4220126

The chemical therapy of breast cancer.

S K Carter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4220126

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

Review 1.  Adjuvant chemotherapy in breast cancer: critique and perspectives.

Authors:  S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Current status and indications for adjuvant therapy in breast cancer.

Authors:  H J Senn
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  A randomized trial of adriamycin, cyclophosphamide, ftorafur (ACF) and adriamycin, cyclophosphamide, ftorafur, methotrexate (ACFM) in patients with advanced breast cancer.

Authors:  K Inoue; M Ogawa; J Inagaki; N Horikoshi; H Miyamoto; K Ikeda; N Usui; H Nakada; K Adachi
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  The influence of estradiol and adriamycin on the RNA biosynthesis in breast cancer.

Authors:  P Schlag; J Veser; G Geier; D Breitig
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

5.  Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.

Authors:  F C Schell; H Y Yap; G N Hortobagyi; B Issell; L Esparza
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 6.  Drug treatment of breast cancer.

Authors:  T E Davis; P P Carbone
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

7.  Antitumor efficacy of seventeen anticancer drugs in human breast cancer xenograft (MX-1) transplanted in nude mice.

Authors:  K Inoue; S Fujimoto; M Ogawa
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.